English
Follow @zeenews
Home
Nation
States
States
Andhra Pradesh
Bihar
Chhattisgarh
Delhi
Goa
Gujarat
Haryana
Himachal Pradesh
Jammu and Kashmir
Jharkhand
Karnataka
Kerala
Madhya Pradesh
Maharashtra
North East
Odisha
Punjab
Rajasthan
Tamil Nadu
Uttar Pradesh
Uttarakhand
UTs
West Bengal
World
South Asia
Business
Auto
Sports
Cricket
Sci-Tech
Showbiz
Health
Exclusive
Blogs
Pics
Videos
Archives
Wednesday, June 19, 2013
Jobs
|
Sitemap
health news
Diseases & Conditions
fitness
ayurveda
Exclusive
Healthy Eating
Low Cal
Recipes
Generic drug
Ranbaxy `systematically violated` good manufacturing practices: Whistl
Ranbaxy Laboratories "systemically violated" good manufacturing practices, says the whisteblower whose alert led to a US probe, a day after India
Views(39)
|
Comments (0)
All medical colleges asked to prescribe generic drugs
The Medical Council of India (MCI) has advised deans of all medical colleges to prescribe generic drugs, parliament was told Tuesday.
Views(30)
|
Comments (0)
Ranbaxy stops production of its generic Lipitor: USFDA
Ranbaxy Laboratories has stopped production of its generic version of cholesterol lowering drug Lipitor.
Views(50)
|
Comments (0)
Lupin launches generic cholesterol lowering drug in US
Drug-maker Lupin Tuesday said its subsidiary Lupin Pharmaceuticals Inc has launched cholesterol lowering drug Fenofibrate tablets in 48mg and 145
Views(88)
|
Comments (0)
Cipla slashes cancer drug prices by up to 64%
Giving some relief to cancer patients, pharma major Cipla today slashed prices of its three generic cancer drugs by up to 64 per cent.
Views(461)
|
Comments (4)
‹
1
2
3
4
5
6
7
8
9
10
›
Other News
Lupin gets USFDA approval for generic Lexapro tablets
Wockhardt gets USFDA nod for generic Parkinson’s drug
Ranbaxy launches generic diabetes drug in US
Wockhardt to launch generic version of Plavix
US pushing India to hike cancer drug price
Kimberley Walsh feels beautiful by doing body basics
Beautiful smile: Dental makeover on the upswing
© 1998-2013 Zee News Limited, All rights reserved
Contact Us
|
Privacy Policy
|
Legal Disclaimer
|
Register
|
Jobs With Us
|
Complaint Redressal
|
Investor info